Health Care · Pharmaceutical Preparations · NYSE · CIK 1962011 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.30Day −2.92%Mkt cap $6M1Y −65.3%Off 52W high −85.8%Vol (1Y) 88.1%
Daily closing price, split-adjusted to the current basis; 1.8y shown of 458 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.9% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.07% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$5.8M |
| ROE−98.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−57.9% |
| 1Y−65.3% |
| Since incept. (ann.)−68.7% |
Total return through 2026-07-29 · series begins 2024-09-16. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)88.1% |
| Ann. volatility (3Y)149.8% |
| Sharpe (1Y)−0.82 |
| Sharpe (3Y)−0.19 |
| Max drawdown (1Y)−85.5% |
| Max drawdown (3Y)−89.0% |
| Beta (3Y vs SPY)1.77 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 231,878 | $129,620 | 1.08% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 111,290 | $62,210 | 0.52% | +52.8% |
| VANGUARD FIDUCIARY TRUST CO | 63,884 | $35,711 | 0.30% | new |
| SevenBridge Financial Group, LLC | 44,286 | $30,331 | 0.21% | +0.0% |
| Aptus Capital Advisors, LLC | 44,286 | $24,756 | 0.21% | +0.0% |
| TWO SIGMA INVESTMENTS, LP | 39,543 | $22,105 | 0.18% | −57.9% |
| STATE STREET CORP | 24,100 | $13,472 | 0.11% | +0.0% |
| HRT FINANCIAL LP | 21,575 | $12,000 | 0.10% | +1.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.08 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$0.07 | — | — | — |
| 2025-06-30 | 2025-08-12 | −$0.08 | — | — | — |
| 2025-03-31 | 2025-05-14 | −$0.08 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 94d) — not company-confirmed.
Item Four 91% · Item One Two And Three 9%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
